Marios Georgakis about 1 month ago
I'm often asked how human genetic data can be used to validate drug targets.
In our new @natcardiovascres.nature.com paper, we provide an end-to-end framework for genetically validating IL-6 inhibition for atherosclerotic cardiovascular disease outcomes 🧵